GENETASTIX CORP has a total of 16 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are OSSIANIX INC, INNOVATIVE TARGETING SOLUTIONS INC and PRESTIGE BIOPHARMA PTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Combinatorial chemistry | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Zhu Li | 15 |
#2 | Hua Shaobing Benjamin | 9 |
#3 | Hua Shaobing | 4 |
#4 | Pauling Michelle H | 3 |
#5 | Hua Shaobing B | 2 |
#6 | Lin Yu-Huei | 2 |
#7 | Sheridan James | 2 |
#8 | Shaobing Hua | 1 |
#9 | Li Zhu | 1 |
#10 | Wei Shuanghong | 1 |
Publication | Filing date | Title |
---|---|---|
US2004067532A1 | High throughput generation and affinity maturation of humanized antibody | |
AU2003209059A1 | Human monoclonal antibodies against membrane proteins | |
US7138496B2 | Human monoclonal antibodies against human CXCR4 | |
US7005503B2 | Human monoclonal antibody against coreceptors for human immunodeficiency virus | |
CA2411515A1 | Generation of libraries of antibodies in yeast and uses thereof | |
US6610472B1 | Assembly and screening of highly complex and fully human antibody repertoire in yeast | |
US6410246B1 | Highly diverse library of yeast expression vectors | |
US6410271B1 | Generation of highly diverse library of expression vectors via homologous recombination in yeast | |
US6406863B1 | High throughput generation and screening of fully human antibody repertoire in yeast |